Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Exit and other-related costs

Other segment segments

Prescription Technology Solutions
$10M
North American Pharmaceutical
$1M

Similar metrics at other companies

Tyson Foods logo
TSNCorporate and Other — Business Exit Costs
$1.5M
Altria Group logo
MOSmokeable Products — Exit costs
$2M+100%
Timken logo
TKREngineered Bearings — Exit costs
-$100K
Timken logo
TKRIndustrial Motion — Exit costs
$200K0.0%
American Eagle Outfitters logo
AEOCorporate And Stores — Business Exit Costs1
$3.45M
Clarus Corporation logo
CLAROutdoor — Business Exit Costs1
$320K+967%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:BusinessExitCosts1.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026 / North American Pharmaceutical (1)Three Months Ended June 30, 2026 / Prescription Technology Solutions (1)Three Months Ended June 30, 2026 / Medical-Surgical Solutions (1)Three Months Ended June 30, 2026 / Corporate (1)Total
Severance and employee-related costs, net$11$14$7$32
Exit and other-related costs (2)11093757
Asset impairments and accelerated depreciation140647
Total$2$61$23$50$136

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — exit and other-related costs?
McKesson (MCK) reported medical-surgical solutions — exit and other-related costs of $9M in Q2 2026.
How has McKesson's medical-surgical solutions — exit and other-related costs changed year-over-year?
McKesson's medical-surgical solutions — exit and other-related costs decreased by 25.0% year-over-year, from $12M to $9M.
What is the long-term trend for McKesson's medical-surgical solutions — exit and other-related costs?
Over 4 years (2022 to 2026), McKesson's medical-surgical solutions — exit and other-related costs has grown at a 64.9% compound annual growth rate (CAGR), from $5M to $37M.
What does medical-surgical solutions — exit and other-related costs mean?
This metric captures the costs associated with exiting specific business activities, facilities, or product lines within the Medical-Surgical Solutions segment. It includes expenses related to lease terminations, contract cancellations, and other non-recurring costs tied to strategic business exits.

Ask your AI about McKesson's medical-surgical solutions — exit and other-related costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude